Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-protein coupled bile acid receptor 1 (GPBAR1), also known as TGR5, is a G protein-coupled receptor that binds bile acids and mediates their signaling effects. Activation of GPBAR1 leads to increased cAMP levels, ERK activation, GLP-1 secretion, and anti-inflammatory effects. It is expressed in various tissues, including the gastrointestinal tract, liver, immune system, and nervous system. GPBAR1 is a promising target for diabetes treatment, but safety concerns regarding gallbladder toxicity need to be addressed.
Agonism leading to increased cAMP levels and ERK activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein coupled bile acid receptor 1 (GPBAR1).